Pragati is responsible for all aspects of HealthAdvance™ – an NIH co-sponsored commercialization funding program for life sciences innovation with an impact on human health. She has 13 years of hands-on research experience spanning both physical and biological sciences. Prior to joining the Innovation Ventures team, she spent two years as an NIH IRACDA fellow designing CRISPR tools to understand gene expression regulation and faithful transmission of epigenetic marks in cellular generations. Prior to that, Pragati was conducting early-stage, pre-clinical research with a goal of repurposing FDA-approved small molecule drug libraries to develop a novel class of anti-fungal therapeutics. Pragati also serves as an ad hoc grant writer/editor for Rutgers startups in need.
Pragati earned her Ph.D. in Biochemistry and Molecular Biology from Rutgers University and holds an MS(Honors) in Analytical Chemistry from Panjab University, India.